Anika Therapeutics Newsroom

Anika Therapeutics Is Maintained at Outperform by Barrington Research

Dow JonesNov 1 11:23 ET

Anika Therapeutics Analyst Ratings

BenzingaNov 1 11:14 ET

Barrington Maintains Anika Therapeutics(ANIK.US) With Buy Rating, Cuts Target Price to $25

Moomoo NewsNov 1 10:31 ET

Barrington Maintains Anika Therapeutics(ANIK.US) With Buy Rating, Maintains Target Price $37

Moomoo NewsOct 22 09:34 ET

Analysts Are Bullish on Top Healthcare Stocks: Chromadex (CDXC), Anika Therapeutics (ANIK)

TipRanksOct 22 09:27 ET

Anika Therapeutics Analyst Ratings

BenzingaAug 9 17:45 ET

Buy Rating Affirmed for Anika Therapeutics Amid Solid Financials and Strong Market Outlook

TipRanksAug 9 09:39 ET

Anika Therapeutics Analyst Ratings

BenzingaMay 29 09:24 ET

Anika Therapeutics Analyst Ratings

BenzingaMay 9 12:17 ET

Analysts Are Bullish on These Healthcare Stocks: Mineralys Therapeutics, Inc. (MLYS), Anika Therapeutics (ANIK)

TipRanksMay 9 11:15 ET

Anika Therapeutics: Strong Q4 Performance and Upbeat FY2024 Outlook Justify Buy Rating and Raised Price Target

TipRanksMar 14 10:20 ET

Anika Therapeutics Analyst Ratings

BenzingaMar 14 09:57 ET

Barrington Research Maintains Outperform on Anika Therapeutics, Raises Price Target to $29

BenzingaJan 3 10:12 ET

Anika Therapeutics Analyst Ratings

BenzingaJan 3 10:10 ET

Anika Therapeutics Receives Buy Rating Based on Strong Q3 Performance and Positive 2023 Outlook

TipRanksNov 3, 2023 09:16 ET

Anika Therapeutics (ANIK) Receives a Buy From Barrington

TipRanksSep 21, 2023 11:22 ET

Barrington Research Upgrades Anika Therapeutics to Outperform, Announces $24 Price Target

BenzingaAug 14, 2023 08:46 ET

Anika Therapeutics Analyst Ratings

BenzingaAug 14, 2023 08:44 ET

Stephens & Co. Maintains Equal-Weight on Anika Therapeutics, Lowers Price Target to $23

BenzingaAug 10, 2023 10:16 ET

Anika Therapeutics Analyst Ratings

BenzingaAug 10, 2023 10:15 ET